Keep taking enzalutamide as you have been told by your doctor or other health care provider, even if you feel. Dec 16, 2019 following single oral administration of 14 c enzalutamide 160 mg, 85% of the radioactivity is recovered by 77 days post dose. Enzalutamide for metastatic hormone relapsed prostate cancer. A profile of enzalutamide for the treatment of advanced. Do not take more than your prescribed dose in one day. Downloadable patient resources xtandi enzalutamide. Most prostate cancers need the hormone testosterone to grow. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer terrain. Pdf emerging mechanisms of enzalutamide resistance in. Xtandi enzalutamide capsules, for oral use initial u. Xtandi enzalutamide was approved by the food and drug administration fda for the treatment of a type of prostate cancer that. Enzalutamide xtandi is a type of hormone therapy for men with prostate cancer that has spread to other parts of the body advanced prostate cancer and has stopped responding to other types of hormone therapy. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for xtandi enzalutamide skip to. Enzalutamide demonstrated a significant improvement in the primary endpoint of overall survival os with a hazard ratio hr of 0.
Enzalutamide is known as an antiandrogen and it works by blocking androgen receptors so that androgens, such as testosterone, cannot bind to the receptor which prevents it from stimulating the cancer. It is a treatment for prostate cancer that has spread to other parts of the body advanced prostate cancer. Advanced prostate cancer treatment xtandi enzalutamide. Product information for auspar xtandi enzalutamide astellas pharma australia pty ltd pm20115514 date of finalisation 24 november 2014. Xtandi 40mg soft capsules patient information leaflet pil. Highlights of prescribing information these highlights do not include all the information needed to use xtandi safely and effectively. In vivo, nilutamide interacts with the androgen receptor and prevents the normal androgenic response. Niosh list of antineoplastic and other hazardous drugs in healthcare settings, 2016. Prevail trial primary endpoints xtandi enzalutamide. If you are allergic to enzalutamide, this may result in a rash or swelling of the face, tongue, lip or throat. Following single oral administration of 14 cenzalutamide 160 mg, 85% of the radioactivity is recovered by 77 days post dose.
Take your prescribed dose as soon as you remember that day. Bottles of 120 capsules ndc 0469012599 recommended storage. If the file has been modified from its original state, some details may not fully reflect the. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for xtandi enzalutamide. An improved and practical synthesis of enzalutamide was accomplished in five steps. Patients with rare hereditary problems of fructose intolerance. Enzalutamide in castrationresistant prostate cancer article pdf available in new england journal of medicine 37914. Restricted access do not disseminate or copy without approval. Xtandi is indicated for the treatment of patients with castrationresistant prostate cancer. Medlineplus information on enzalutamide a lay language summary of important information about this drug that may include the following. For the treatment of patients with metastatic castrationresistant prostate cancer. It also explains the difference between a generic name and generic version of a drug. It blocks the effect of testosterone which is a male sex hormone.
Enzalutamide is also being studied in the treatment of other types of cancer. If alternative treatments cannot be used, consider a dose reduction of the cyp2d6 substrate drug. The ingredients of the soft capsule shell are gelatin, sorbitol sorbitan solution see section 2, glycerol, titanium dioxide e171, and purified water. Starting from 4bromo2fluorobenzonic acid, a methyl esterification, ullmann ligation, methyl esterification, ring closing reaction and final methyl amidation provided the target in 35% total yield with 99.
In vitro, nilutamide blocks the effects of testosterone at the androgen receptor level. Have a history of seizures, brain injury, stroke, or brain tumors. Patients receiving concomitant capecitabine and oral coumarin. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Seizures occurred in 7 of 800 enzalutamide patients. Do not change or stop taking your prescribed dose of xtandi without talking with your doctor first. It works by blocking the effect of the hormone testosterone on prostate cancer cells. The recommended dose of xtandi is 160 mg four 40 mg capsules administered orally once daily. Enzalutamide in biochemical relapse of prostate cancer in a trial, the median metastasisfree survival among men with nonmetastatic, castrationresistant prostate cancer and a short psa doubling ti. It is indicated for use in conjunction with castration in the treatment of metastatic castrationresistant prostate cancer mcrpc, nonmetastatic castrationresistant prostate cancer, and metastatic castrationsensitive prostate cancer mcspc. By connor th, mackenzie ba, debord dg, trout db, ocallaghan jp.
Tell your doctor about all your medical conditions, including if you. It has been demonstrated impressive affinity to the ar compared to the firstgeneration ar inhibitors. Enzalutamide in men with nonmetastatic, castrationresistant. Zytiga is an inhibitor of the hepatic drugmetabolizing enzymes cyp2d6 and cyp2c8. It is able to inhibit binding of androgens to the ar, ar nuclear translocation, and the association of. Sep 27, 2017 showall page 1 enzalutamide oral chemotherapy education name of your medication generic name enzalutamide enzuhlootuhmide brand name xtandi ekstandee approved uses enzalutamide is used to treat men with prostate cancer dose and schedule taking enzalutamide as instructed is important to allow your treatment to be as effective as possible so here are some key points to. The trial was designed to evaluate patients who were randomized 1.
Xtandi enzalutamide prior auth criteria proprietary information. Xtandi is contraindicated for use in pregnant women because the drug can cause fetal harm and potential. Mdv3100, known as enzalutamide, is a secondgeneration androgen receptor ar signaling inhibitor. Enzalutamide xtandi for prostate cancer chemoexperts. Enzalutamide competitively inhibits binding of androgens to. An improved and practical route for the synthesis of. Xelodawarfarin interaction xeloda warfarin interaction. If you miss a daily dose, take xtandi at your regular time the next day.
Xtandi enzalutamide 40 mg capsules are supplied as white to offwhite oblong soft gelatin capsules imprinted in black ink with enz. Enzalutamide cancer information cancer research uk. Many of these patients had other factors that lowered seizure threshold. This file contains additional information, probably added from the digital camera or scanner used to create or digitize it. Oct 04, 2018 enzalutamide in castrationresistant prostate cancer article pdf available in new england journal of medicine 37914. Have a history of heart disease, have high blood pressure, or have abnormal amounts of fat or cholesterol in your blood. The main findings of this trial have been well reported and hence are covered only briefly here saad, 20. Xtandi contains sorbitol see dosage forms, composition and packaging. Special pediatric considerations are noted when applicable, otherwise adult provisions apply. Xtandi is indicated for the treatment of patients with metastatic castrationresistant prostate cancer who have previously received docetaxel. Xtandi ex tan dee enzalutamide capsules what is xtandi. Patient information xtandi ex tan dee enzalutamide capsules what is xtandi. Enzalutamide in men with chemotherapynaive metastatic castrationresistant prostate cancer.
Enzalutamide is an androgen receptor inhibitor for the treatment of castrationresistant prostate cancer. Avoid coadministration with cyp2d6 substrates with a narrow therapeutic index. Xtandi capsules are available in the following package sizes. If the file has been modified from its original state, some details may not fully reflect the modified file. Niosh list of antineoplastic and other hazardous drugs in. Take your prescribed dose once a day, at the same time each day.
Food and drug administration fda approved a supplemental new drug application snda to update the u. Highlights of prescribing information posterior reversible. Under conditions of clinical use, enzalutamide is a strong inducer of cyp3a4, a moderate. Xtandi is indicated for the treatment of patients with metastatic castration resistant prostate cancer who have previously received docetaxel. Xtandi is indicated for men with castrationresistant prostate cancer crpc, prostate cancer that is. In a cyp2c8 drug interaction trial in healthy subjects, the auc of pioglitazone, a. Enzalutamide drug monograph pharmacy benefit management. Some side effects of enzalutamide may occur that usually do not need medical. Xtandi is an androgen receptor inhibitor indicated for the treatment of patients with. An update on enzalutamide in the treatment of prostate cancer. Xtandi support solutions a is designed as a single point of contact to help patients understand their coverage and reimbursement options when they are prescribed xtandi enzalutamide. Patient information xtandi ex tan dee enzalutamide. In some cases, health care professionals may use the trade name xtandi when referring to the generic drug name enzalutamide.
Enzalutamide is the generic name for the trade name drug xtandi. Enzalutamide is an androgen receptor inhibitor which acts at several steps in the androgen receptor signaling pathway. Enzalutamide for metastatic hormone relapsed prostate. Xtandi is a prescription medicine used to treat men with prostate cancer that. Definition from the nci drug dictionary detailed scientific definition and other names for this drug. There are no generic xtandi enzalutamide products available at this time. Enzalutamide in men with nonmetastatic, castration. This emedtv web page discusses when a generic version of this drug might become available.
A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Enzalutamide, sold under the brand name xtandi, is a nonsteroidal antiandrogen nsaa medication which is used in the treatment of prostate cancer. Enzalutamide xtandi enzalutamide is a type of hormone therapy. Take enzalutamide at around the same time every day.
We are here to answer questions about your insurance coverage or accessing your astellas medication. Dosage may be reduced, delayed or discontinued in patients with bone marrow. Xtandi 40mg soft capsules patient information leaflet. Pdf enzalutamide in castrationresistant prostate cancer. Enzalutamide in patients progressing post docetaxel affirm affirm is the key trial that supports the use of enzalutamide for the treatment of patients with mcrpc postdocetaxel, the first approved indication for enzalutamide scher et al. Enzalutamide uses, dmf, dossier, manufacturer, supplier. It is usually taken with or without food once a day. Highlights of prescribing information perforation can occur. The other ingredients of the soft capsule are caprylocaproyl macrogol8 glycerides, butylhydroxyanisole e320, and butylhydroxytoluene e321. Enzalutamide is medication taken by mouth to slow tumor growth and alleviate symptoms. Fda approves supplemental new drug application for xtandi. This product information was approved at the time this auspar was published. To speak with a dedicated access specialist, please call us at 18558xtandi 18558982634.
501 1433 346 682 838 793 1361 1483 1259 44 529 347 947 1336 1381 182 1364 1242 829 261 1509 667 582 48 312 1477 228 759 9 803 543 866 1126